Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Charcot Marie Tooth Type 2A2 (MFN2) Molecular Genetics Laboratory London Health Sciences Centre Canada | 1 | 1 |
|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 46 | 34 |
|
Mitofusin 2 (MFN2) gene sequencing test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
MFN2 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 3 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene US, LLC - The Rare Disease Company United States | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene US, LLC - The Rare Disease Company United States | 442 | 443 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 406 | 414 |
|
Centogene US, LLC - The Rare Disease Company United States | 417 | 413 |
|
Centogene US, LLC - The Rare Disease Company United States | 325 | 316 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 734 | 744 |
|
MFN2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.